Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: The Women's Health Initiative hormone therapy clinical trials

Marianne Canonico, Geneviève Plu-Bureau, Mary Jo O'Sullivan, Marcia L. Stefanick, Barbara Cochrane, Pierre Yves Scarabin, Joann E. Manson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

OBJECTIVE: This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women. METHODS: Using pooled data from the Women's Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested. RESULTS: During follow-up, 426 women reported a first VTE, including 294 non-procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non-procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95% CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively). CONCLUSIONS: Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non-procedure-related VTE.

Original languageEnglish
Pages (from-to)214-220
Number of pages7
JournalMenopause
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Reproductive History
Venous Thromboembolism
Women's Health
Menopause
Clinical Trials
Hormones
Menarche
Ovariectomy
Parity
Therapeutics
Proportional Hazards Models
Odds Ratio

Keywords

  • Age at menopause
  • Risk factors
  • Venous thromboembolism

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women : The Women's Health Initiative hormone therapy clinical trials. / Canonico, Marianne; Plu-Bureau, Geneviève; O'Sullivan, Mary Jo; Stefanick, Marcia L.; Cochrane, Barbara; Scarabin, Pierre Yves; Manson, Joann E.

In: Menopause, Vol. 21, No. 3, 01.03.2014, p. 214-220.

Research output: Contribution to journalArticle

Canonico, Marianne ; Plu-Bureau, Geneviève ; O'Sullivan, Mary Jo ; Stefanick, Marcia L. ; Cochrane, Barbara ; Scarabin, Pierre Yves ; Manson, Joann E. / Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women : The Women's Health Initiative hormone therapy clinical trials. In: Menopause. 2014 ; Vol. 21, No. 3. pp. 214-220.
@article{96a91e84b3e44503923dfc2eb34a4d5c,
title = "Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: The Women's Health Initiative hormone therapy clinical trials",
abstract = "OBJECTIVE: This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women. METHODS: Using pooled data from the Women's Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested. RESULTS: During follow-up, 426 women reported a first VTE, including 294 non-procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non-procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95{\%} CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively). CONCLUSIONS: Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non-procedure-related VTE.",
keywords = "Age at menopause, Risk factors, Venous thromboembolism",
author = "Marianne Canonico and Genevi{\`e}ve Plu-Bureau and O'Sullivan, {Mary Jo} and Stefanick, {Marcia L.} and Barbara Cochrane and Scarabin, {Pierre Yves} and Manson, {Joann E.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1097/GME.0b013e31829752e0",
language = "English",
volume = "21",
pages = "214--220",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women

T2 - The Women's Health Initiative hormone therapy clinical trials

AU - Canonico, Marianne

AU - Plu-Bureau, Geneviève

AU - O'Sullivan, Mary Jo

AU - Stefanick, Marcia L.

AU - Cochrane, Barbara

AU - Scarabin, Pierre Yves

AU - Manson, Joann E.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - OBJECTIVE: This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women. METHODS: Using pooled data from the Women's Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested. RESULTS: During follow-up, 426 women reported a first VTE, including 294 non-procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non-procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95% CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively). CONCLUSIONS: Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non-procedure-related VTE.

AB - OBJECTIVE: This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women. METHODS: Using pooled data from the Women's Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested. RESULTS: During follow-up, 426 women reported a first VTE, including 294 non-procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non-procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95% CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively). CONCLUSIONS: Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non-procedure-related VTE.

KW - Age at menopause

KW - Risk factors

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84896739853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896739853&partnerID=8YFLogxK

U2 - 10.1097/GME.0b013e31829752e0

DO - 10.1097/GME.0b013e31829752e0

M3 - Article

C2 - 23760439

AN - SCOPUS:84896739853

VL - 21

SP - 214

EP - 220

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 3

ER -